ArticleClinical and experimental immunology2024

Screening and anti-angiogenesis activity of Chiloscyllium plagiosum anti-human VEGFR2 single-domain antibody.

Yanwen Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.